Fexapotide triflutate

N/A

Report date: 2025/12/29 10:48:45

Base Information

Drug NameFexapotide triflutate
Drug Alias NameNX-1207REC-0482
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCellular inhibitor of apoptosis protein 1 stimulants
TargetsCellular inhibitor of apoptosis protein 1
Therapy Area/IndicationsLower Urinary Tract SymptomsProstatic HyperplasiaProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNymox Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNymox CoRecordati Spa
Active IndicationsN/A
Inactive IndicationsLower Urinary Tract SymptomsProstatic HyperplasiaProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A